Technetium (99mTc) sulesomab

Technetium (99mTc) sulesomab
Monoclonal antibody
Type Fab' fragment
Source Mouse
Target NCA-90 (granulocyte cell antigen)
Clinical data
ATC code V09HA04 (WHO)
Legal status
Legal status
  • Approved for use in Australia
CAS Number 167747-19-5 N (unlabelled)
ChemSpider none
 NYesY (what is this?)  (verify)

Technetium (99mTc) sulesomab (trade name LeukoScan) is a mouse monoclonal antibody[1] labelled with technetium-99m, a radionuclide.

It is approved for the imaging of infections and inflammations in patients with suspected osteomyelitis,[2] and is being investigated for other purposes like the detection of soft tissue infections.[3]


  1. WHO Drug Information
  2. EMEA: Summary of product characteristics (LeukoScan)
  3. Quigley, A. M.; Gnanasegaran, G.; Buscombe, J. R.; Hilson, A. J. W. (2008). "Technetium-99m-Labelled Sulesomab (LeukoScan) in the Evaluation of Soft Tissue Infections". Medical Principles and Practice. 17 (6): 447–52. doi:10.1159/000151565. PMID 18836272.

Emily is bloody fantastic. This is all.

This article is issued from Wikipedia - version of the 8/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.